PREPAREDNESS TODAY, SAFER TOMORROW.

Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health

WINNIPEG, Manitoba, May 01, 2025 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced a maximum three-year agreement with a value of approximately $65 million to supply the Ontario Ministry of Health with NARCAN® Nasal Spray for the Ontario Naloxone Program (ONP). Since 2018, Emergent has supported the Ontario Ministry of Health to provide access to NARCAN® Nasal Spray across the province.

Emergent Presents ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) Historical Safety Data at World Vaccine Congress

Emergent BioSolutions will present an overview of historical safety data for ACAM2000® on Thursday, April 24, 2025, at World Vaccine Congress in Washington, D.C. The presentation will be held at 10:10 am eastern time at the Walter E. Washington Convention Center in room 202B and is available to all World Vaccine Congress conference pass holders.